A Framework for Writing and Critically Evaluating Guideline Articles

OPEN IN VIEWER

Chandan K. Sen

Guidelines for biomedical research and clinical practice are systematically developed recommendations designed to standardize care, enhance patient safety, and ensure ethical and scientific rigor in medicine. Their primary objectives include improving rigor and reproducibility in scientific studies, improving health care quality, reducing variability in practice, and translating evidence into actionable steps for clinicians and researchers. Historically, the need for guidelines emerged in the mid-20^th century with the rise of evidence-based medicine, as increasing medical complexity and ethical concerns—highlighted by incidents like the Tuskegee Syphilis Study—demanded structured frameworks such as the Belmont Report ¹ and Declaration of Helsinki. ^2,3

Early guidelines often relied on expert opinion rather than credible consensus among key opinion leaders with peer-reviewed expertise. Today, guidelines integrate the latest research, ethical principles, and expert consensus to promote best practices while adapting to advancements in medical science. Efforts such as GRADE (Grading of Recommendations Assessment, Development, and Evaluation) and regulatory oversight (e.g., WHO, NIH, NICE), when applicable, have since improved rigor, transparency, and applicability. ^4,5 The GRADE approach is a systematic and transparent framework for assessing the quality of evidence and strength of recommendations in health care guidelines. It is well-suited to support clinical practice guidelines, health policy, and public health recommendations; comparative effectiveness research; and diagnostic test guidelines. For example, adapted GRADE for diagnostics (GRADE-D ⁴ ) assesses indirectness (e.g., lab-based versus real-world performance) and imprecision (confidence intervals around accuracy estimates). GRADE is not well suited for emerging fields with sparse evidence. Also, the GRADE approach is highly time-intensive. Although GRADE emphasizes transparency, multidisciplinary representation, and conflict-of-interest (COI) management to ensure credible and unbiased recommendations, it does not prescribe a specific method for selecting credible guideline authors or panel members. For formal guidance, many groups combine GRADE with GIN (Guidelines International Network) ^6,7 or IOM ⁸ standards for panel selection.

The Oxford Center for Evidence-Based Medicine (CEBM) focuses on hierarchical ranking of study designs such that RCTs>cohort studies, etc. Compared to GRADE, CEBM is simpler but less transparent in moving from evidence to recommendations. ⁹ GRADE evaluates certainty of evidence beyond study design and explicitly weighs benefits/harms. CEBM is mostly used in the United Kingdom and Europe. For preventive services, the US Preventive Services Task Force (USPSTF) system is relevant. ¹⁰ It uses certainty of net benefit (high, moderate, and low) and letter grades. USPSTF is as rigorous as GRADE but only applicable to preventive services. It is commonly used for USPSTF screening guidelines such as mammography ^11,12 and statin. ¹³ The National Institute for Health and Care Excellence (NICE) approach uses GRADE-like methods but integrates cost-effectiveness (via health economic modeling). ⁵ NICE is more prescriptive on economic evaluations. GRADE is agnostic on cost unless using an Evidence-to-Decision (EtD) framework. The WHO Evidence-to-Decision (EtD) frameworks expand GRADE to include equity, feasibility, and acceptability. ^14,15 WHO EtD is GRADE-based but more policy-oriented. ¹⁵ Standard GRADE is more clinical.

In general, comparing GRADE with the Institute of Medicine (IOM) standards (currently the National Academy of Medicine, NAM) and the Guidelines International Network (GIN) standards, key differences emerge in their focus, rigor, and application in guideline development. IOM standards focus on trustworthiness and procedural rigor. The IOM approach is stricter than GRADE in limiting panelists with COI. It mandates the inclusion of patients, methodologists, and credible, diverse stakeholders. IOM requires formal systematic reviews somewhat akin to that required by GRADE but less structured on grading evidence. IOM places key emphasis on transparency by requiring detailed documentation of processes and voting records. While GRADE is best applied to clinical and healthcare policy questions, IOM principles may be more broadly applicable for guideline development. In the wound care domain, where COI risks are high, adaptation of IOM principles are recommended.

For global best practice, the GIN standards support guideline development and adaptation. ^6,7 The ADAPTE framework is specifically dedicated to adapting existing guidelines. ^16,17 This is useful to adapt guidelines across regions (e.g., European versus Asian Protocols). ADAPTE is complementary. It can use GRADE for evidence assessment during adaptation. GRADE is better for new guideline creation. Compared to GRADE, GIN standards have a stronger focus on patient engagement. Specifically, it offers detailed support on implementation planning. It is more explicit than GRADE on real-world rollout. International harmonization is a direct focus of GIN. On evidence grading, GIN standards often endorse GRADE.

For guideline development, GRADE, IOM, and GIN rest on shared foundations. All three emphasize systematic reviews, transparency, and credible multidisciplinary panel selection. Many IOM- and GIN-compliant guidelines use GRADE for evidence grading (e.g., WHO, NICE). These three approaches have complimentary roles. While IOM focuses on Process Rigor asking, “Is the guideline credible?”, GRADE focuses on scientific rigor, asking, “How strong is the evidence?” GIN standards aim at practical rigor, asking, “Will this guideline work in practice?” Thus, hybrid use cases are strongly encouraged. For example, a U.S. guideline might follow IOM standards for panel selection, GRADE for evidence assessment, and GIN tools for implementation planning.

The opinions of a few experts, when not grounded in standardized guideline development criteria, often lack credibility due to their susceptibility to bias, inconsistency, and lack of transparency. Unlike formal frameworks such as GRADE, IOM, or GIN—which enforce systematic evidence synthesis, multidisciplinary input, and explicit conflict-of-interest management—ad hoc expert opinions may reflect individual preferences, institutional biases, or limited perspectives rather than robust, evidence-based consensus. While such opinion articles can be valuable contributions to literature, in the interest of rigor, caution must be exercised while designating them as “Guidelines.” Without structured and transparent methodologies to select an author panel, assess evidence quality, weigh risks and benefits, or incorporate patient values, such recommendations risk being arbitrary, unreproducible, and potentially influenced by undisclosed conflicts. Credible guidelines require rigorous and transparent processes to ensure reliability, fairness, and applicability. Expert opinions alone, no matter how distinguished the source, cannot substitute for transparent, standardized approaches trusted by scientists, clinicians, policymakers, and patients alike.